av-1980r
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 15, 2025 (NCT07158905)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Microtubule-associated protein tauImmunity, active
MAPT immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07158905 | Phase 1 | Dec 15, 2025 | Institute for Molecular Medicine, National Institute on Aging (NIA) |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Institute for Molecular Medicine | Academic/Hospital | 1 | 1 | 1 | 2025 |
| National Institute on Aging (NIA) | Government | 1 | 0 | 1 | 2025 |
2 organizations
Page 1 / 1